Weiss Multi Strategy Advisers LLC Tyme Technologies, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

$0
Q1 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Feb 14, 2020	SELL	$1.0 - $1.49 $53,500 - $79,715	-53,500 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$0.97 - $1.77 $6,305 - $11,505	-6,500 Reduced 10.83%	53,500 $64,000
Q2 2019 Aug 14, 2019	SELL	$0.96 - $1.89 $9,600 - $18,900	-10,000 Reduced 14.29%	60,000 $73,000
Q4 2018 Feb 14, 2019	SELL	$2.01 - $4.21 $160,799 - $336,800	-80,000 Reduced 53.33%	70,000 $258,000
Q3 2018 Nov 14, 2018	SELL	$2.18 - $3.44 $10,900 - $17,200	-5,000 Reduced 3.23%	150,000 $417,000
Q2 2018 Aug 14, 2018	SELL	$2.05 - $4.09 $71,750 - $143,150	-35,000 Reduced 18.42%	155,000 $490,000
Q1 2018 May 15, 2018	BUY	$2.12 - $7.0 $402,800 - $1.33 Million	190,000 New	190,000 $424,000

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.